Koninklijke Philips N.V. PHG
Regular-session close
After hours · Nov 20, 4:00 PM ET
- YTD
- +5.65%
- 1 year
- +7.11%
5D -0.41 (-1.34%)
- Market cap
- 27.97B
- Revenue (ttm)
- 17.76B
- Profit margin
- 5.39%
- EPS (ttm)
- 1.15
- Shares out
- 977.61M
- P/E ratio
- 24.88
- Forward P/E
- 14.04
- Dividend
- 1.01 (3.46%)
- Ex-dividend date
- May 13, 2026
- YTD return
- +5.65%
- 1-year return
- +7.11%
- Volume
- 2.42M
- Avg volume
- 1.17M
- Open
- 28.89
- Previous close
- 29.25
- Day's range
- 28.56 – 29.14
- 52-week range
- 23.62 – 33.44
- Beta
- 0.81
- Analysts
- Hold
- Price target
- 33.88 (+18.4%)
- Earnings date
- Feb 9, 2027
- 50-day average
- 26.51
Key statistics
- 200-day average
- 27.25
- Enterprise value
- 34.01B
- PEG ratio
- 0.90
- Price / sales
- 1.57
- Price / book
- 2.15
- Payout ratio
- 87.71%
- Revenue growth
- 2.10%
- Free cash flow
- 1.85B
- Total cash
- 2.75B
- Total debt
- 8.14B
- Return on equity
- 8.61%
Fundamental scorecard
8 of 25 checks passed on PHG’s reported financials
8of 25 checks passed
- Value 0 of 5
- Growth 1 of 5
- Profitability 2 of 5
- Financial health 3 of 5
- Dividend 2 of 5
Statements to Dec 31, 2025.
Analyst view
Consensus: hold
- Target (low)
- 29.70
- Target (mean)
- 33.88
- Target (high)
- 41.00
- Strong buy2
- Buy0
- Hold3
- Sell0
- Strong sell0
Next earnings
Feb 9, 2027
Expected Feb 9, 2027. Consensus EPS estimate 0.61285.
Financials — quick view
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Feb 9, 2027 | Dec 30, 2026 | 0.61 | — | — | — |
| Nov 3, 2026 | Sep 30, 2026 | 0.37 | 0.46 | +0.09 | +24.32% |
| Jul 27, 2026 | Jun 30, 2026 | 0.40 | 0.57 | +0.17 | +42.50% |
| May 6, 2026 | Mar 31, 2026 | 0.24 | 0.27 | +0.03 | +12.50% |
| Feb 10, 2026 | Dec 31, 2025 | 0.565 | 0.70 | +0.14 | +23.89% |
| Nov 4, 2025 | Sep 30, 2025 | 0.37 | 0.37 | 0.00 | 0.00% |
Upgrades / downgrades
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Aug 3, 2026 | UBS | down | Buy | Neutral |
| Feb 20, 2025 | UBS | up | Neutral | Buy |
| Oct 29, 2024 | Jefferies | up | Underperform | Hold |
| May 13, 2024 | Bernstein | up | Market Perform | Outperform |
| Apr 30, 2024 | UBS | up | Sell | Neutral |
| Apr 30, 2024 | JP Morgan | up | Underweight | Neutral |
About Koninklijke Philips N.V.
Koninklijke Philips N.V. operates as a health technology company in North America, the Greater China, and internationally. It operates through Diagnosis & Treatment, Connected Care, and Personal Health segments. The company provides diagnostic imaging solutions, includes ultrasound business unit, magnetic resonance imaging, computed tomography, and diagnostic x-ray; Image Guided Therapy, including image guided therapy systems and image guided therapy devices. It also offers monitoring, enterprise informatics, and sleep and respiratory care, as well as personal health. Koninklijke Philips N.V. has strategic alliance with WellSpan Health to advanced imaging and diagnostics technology products and platforms. The company was formerly known as Koninklijke Philips Electronics N.V. and changed its name to Koninklijke Philips N.V. in May 2013. Koninklijke Philips N.V. was founded in 1891 and is headquartered in Amsterdam, the Netherlands.
- Sector
- Healthcare
- Industry
- Medical Devices
- Country
- Netherlands
- Website
- philips.com
News
Philips Unveils Skylight Device Manager to Boost Ultrasound Efficiency
Philips introduces Advanced Image Insights for advanced visualization and AI orchestration
Philips introduces Skylight Device Manager to turn ultrasound data into operational intelligence
Here's Why You Should Retain PHG Stock in Your Portfolio for Now
Philips to nominate Dick Boer, Laurence Debroux and Todd Brinton to its Supervisory Board at the 2027 Annual General Meeting of Shareholders (AGM)
Philips Reports Strong Customer Demand, Improved Profitability
Koninklijke Philips Q3 2026 Earnings Call Transcript Philips Reiterates FY2026 Outlook: Comparable Sales Growth 3%-4.5%, Adjusted EBITA Margin 13.5%-14.0%, Free Cash Flow EUR 1.5B-1.7B, Including US Tariff Refund Benefits
Koninklijke Philips Q3 Adj. EPS $0.46 Beats $0.37 Estimate, Sales $5.055B Beat $4.990B Estimate
Your note
Sign in to keep a note on PHG — it syncs with the Stock Master app.
Institution ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Exor N.V. | 18.92% | 185,932,684 | 5.32B | Sep 29, 2026 |
| Mondrian Investment Partners Ltd | 0.80% | 7,885,781 | 225.57M | Sep 29, 2026 |
| Dimensional Fund Advisors LP | 0.45% | 4,407,860 | 126.09M | Sep 29, 2026 |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC | 0.36% | 3,527,309 | 100.90M | Sep 29, 2026 |
| Fiduciary Management, Inc. | 0.34% | 3,293,051 | 94.20M | Sep 29, 2026 |
| Causeway Capital Management LLC | 0.30% | 2,994,537 | 85.66M | Sep 29, 2026 |
Fund ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| FMI Funds Inc-Large Cap Fund | 0.12% | 1,160,000 | 33.18M | Sep 29, 2026 |
| Dimensional ETF Trust-Dimensional International Value ETF | 0.10% | 995,485 | 28.48M | Jul 30, 2026 |
| DFA INVESTMENT DIMENSIONS GROUP INC-Intl Core Eqy. 2 PORT. | 0.10% | 1,017,635 | 29.11M | Jul 30, 2026 |
| DFA INVESTMENT TRUST CO-The DFA International Value Series | 0.06% | 630,121 | 18.02M | Jul 30, 2026 |
| Liberty All Star Equity Fund | 0.05% | 454,135 | 12.99M | Jun 29, 2026 |
| Dimensional ETF Trust-Dimensional International Core Equity 2 ETF | 0.04% | 388,912 | 11.12M | Jul 30, 2026 |
